CMS move to curb 340B duplicate claims flawed, hospitals in program warn
CMS issued new guidance Jan. 8 intended to help state Medicaid programs avoid submitting duplicate rebate claims for drugs that already get a 340B discount, but a group representing hospitals that participate in the drug-pricing program warns the guidance could undercut the purpose of the program.
The guidance lays out seven strategies for avoiding duplicate discounts, which HealthPayerIntelligence reports has cost CMS $160.8 million.
